LGD-4033
most data
The Dose Guy’s verdictSep 1, 20263 sources
LGD-4033 is the mass SARM. It builds real size and strength, which is why people reach for it, and it suppresses testosterone, crushes lipids, and holds water, which is why you need to plan the recovery before you start the cycle. It is not the gentle option. If you want mild, run ostarine. If you want mass and accept the commitment, LGD-4033 delivers, but treat it with the same respect you would give a light oral anabolic.
What it is
LGD-4033 is a nonsteroidal oral selective androgen receptor modulator developed for muscle wasting and osteoporosis. It is the mass builder of the popular SARMs, the one people reach for when size is the goal, and it has human trial data proving the mechanism works, even though that trial ran at doses far below what the community uses. The receptor binding is potent, the muscle signal is real, and so is the suppression that rides with it.
Among SARMs, LGD-4033 is the size choice. RAD-140 matches it for strength but runs drier and more aggressive. Ostarine is milder in every direction: less mass, less suppression, less to recover from.
What the research shows
One short human trial and a stack of case reports. The trial proved the mechanism at tiny doses. The case reports show what happens at community doses:
Realistic protocols
People run LGD-4033 at 5 to 10 mg a day, orally, for eight weeks. Start at 5. Strength and fullness show up fast, usually inside the first two weeks, and 5 mg is enough for most first cycles. Going to 10 adds more water, more suppression, and more mass, in that order. Past 10, diminishing returns set in hard.
Expect water retention. LGD-4033 holds noticeably more water than RAD-140 or ostarine, and that weight comes off when you stop. It is not fat and it is not all muscle. Set your expectations before you weigh yourself.
Skip the alcohol. The liver signal in the case reports is real, and adding alcohol on top of an androgen that already stresses liver enzymes is the combination that lands people in trouble.
PCT is mandatory. LGD-4033 suppresses testosterone, and the trial proved it: total testosterone, SHBG, and HDL all dropped in a dose-dependent pattern, with FSH and free testosterone significantly suppressed at the 1.0 mg dose. The community runs five to ten times that. A SERM for four weeks after the cycle is standard. Nolvadex at 20 mg a day or enclomiphene at 12.5 mg, starting about a week after the last dose. LGD-4033 clears slowly and accumulates with daily dosing, so starting the SERM while the compound is still active wastes the first week. Bloodwork before and after is the minimum.
LGD-4033 is WADA-banned. Its urine metabolites stay detectable for up to 21 days after the last dose. If you are tested, there is no short window.
A third-party COA is not a formality. That JAMA analysis found the product on the label was wrong more often than right.
Side effects
Stronger than ostarine, and the sides match:
